ZLATOMICS
Strategic Differentiators and Portfolio Advantage
1. Scientific Innovation at the Molecular and Computational Frontier
Platform-Driven Value
Creating a decentralized, incentive-driven network for genomic discovery (Genomics on the Blockchain) and harnessing DNA Computers in Living Tissues for biological data storage and computation.
Direct Therapeutic Impact
We target individual molecular players that have the power to overturn bottlenecks in medicine. We leverage Molecular Chaperones as genomic therapeutic targets and utilize Transcript Isoforms to contribute to development of direct gene regulatory medicines.
Next-Generation AI
Our AI-Enhanced Genomics Reasoning expands the internal scientific knowledge of large language models, moving beyond simple data processing to enable scientific and applied use for discovery.
Modern Scope & Originality
We start as a tabula rasa, tackling modern, new topics without being constrained by competitor actions. We guarantee that the work delivered is free of redundancy, repetition, or rehashed ideas - it is distinctive and original.
2. Non-Traditional Financial & Strategic Modeling
Proprietary Biotech Salvage
Our Biotech Venture Salvage model exploits the assets of distressed small, non-biotech businesses to reconstruct biotech enterprises. This method creates value by leveraging existing assets, not additional capital.
Reality-Based Valuation
We provide Competitive Intelligence, specializing in the objective reassessment and correction of a technology's true value (e.g., Prime Editing), ensuring client capital is allocated based on clear scientific merit, not market hype.
Predictive Research & R&D
Our R&D approach incorporates in silico modeling to predict and prioritize high-probability outcomes, ensuring scientific effort is focused on the most promising avenues (e.g., Agritech Manufacturing for weight-loss management).
3. Optimized Partnership Model & Operational Efficiency
Efficient Outsourcing
We provide on-demand access to a highly skilled scientist with business acumen, offering a flexible, cost-effective, and efficient all-in-one alternative to permanent headcount.
Guaranteed Quality
Clients rely on us for managing high workloads, focused scientific support, and for an independent secondary opinion or a salvaging pathway guaranteed to work, knowing we deliver work free of redundancy.
Mission Alignment
We are passionate about complex human diseases and overcoming healthcare challenges. All consulting profits are reinvested into our proprietary innovations under
Zlatomics R&D, directly aligning our financial success with our commitment to scientific advancement.
Founder's Core Competencies & Track Record
1. Execution & Operational Style
Scientific Execution
Known for single-handed scientific execution; was the go-to person among peers because she made
every experiment work.
Written Dominance
Never lost any written dispute or argument (non-legal or legal, with either scientific reviewers, contractors, or local governments) due to written persuasive skills and an ability to defend strategic positions.
Efficiency & Velocity
Disliking long meetings when not necessary, preference is to get the work done, contributing to high operational velocity and efficient use of client time.
Lean Structure
Using too much AI (commercially available or self-made) instead of headcount can be viewed as a downside, but it is a strategic advantage for clients due to lower overhead, faster scaling, and resource efficiency.
Communication
Described as a direct communicator and an effective innovator.
2. Academic, Funding, & Enterprise Track Record
High-Status Awards
An accomplished scholar with high-academic status awards including a National Research Service Award and a Merck Fellowship.
Institutional Pedigree
Held research and academic positions at top-tier global institutions, including Harvard Medical School (USA), Technical University of Munich (Germany's top technical school), and KAUST (the top research university in the Middle East).
Funding Acumen
Proven track record of securing independent funding such as Angel Investor Funding for startup; NIH and Merck funding (USA) and DAAD funding (Germany) for academic work.
Client Portfolio
Serving as a strategic partner to biotechs, pharma, academia, private equities, and other consulting practices.
Product Development
Independently developed a product from concept to MVP, demonstrating end-to-end innovation capability.
Unique Recognition
First Serbian not born in the US, nor holding an official degree in the US, to receive a F32 grant highlighting academic achievement against structural barriers.
Industry Experience
Recently held positions at Moderna, Harvard Medical School, and the University of Illinois. Before that, worked as Researcher and Intern at the Technical University of Munich, KAUST & MIT in Asia, and Greifswald and JKU in Europe.
Business Scope
Familiar with the biotech, pharma, and small business enterprise landscape, enabling capitalization on collaborative opportunities.
3. Expertise & Versatility
Scientific Expertise
Over 13 years in genomics and over 16 years in biotechnology; deep expertise across molecular life sciences (genomics, molecular biology, biochemistry, proteomics, bioinformatics).
See more here.
Interdisciplinary Breadth
Early academic work spanned
computational chemistry, analytical chemistry, cellular biophysics, immunology, and oncology; has an ability to apply knowledge across diverse scientific disciplines.
Technical Skills
Skilled in most biotechnology/molecular biology techniques; developed the
5'-Seq NGS technique single-handedly (solo author).
Versatility and Multifaceted Skills
Global Perspective
Worked and studied across three continents and at leading international institutions, providing a uniquely broad, adaptive, and international perspective. Speaks 3 languages fluently and understands many of them.
Personal Drive/Narrative
Built an independent empire after arriving in the country with one luggage.
4. Side Ventures Drives
Other Ventures
Involved in real estate, fintech, agriculture, fashion, and occasional scandals.
Don't miss out on the future of biotechnology. We can help you unlock its potential.
Genomics consulting biotechnology consulting DNA gene editing guideRNA crispr screen FLAP Prime editing Gene Editing Genomics NGS Next Generation Sequencing High Throughput Sequencing High Throughput Screening Leadership Nanopore Sequencing Project Management Mentoring Assay Development Crispr Automation Liquid handler Chemically modified RNA Mammalian Cell Culture Operational Planning Research and Development (R&D) DNA Extraction RNA extraction Scientific Presentation Interdisciplinary Collaboration Molecular & Cellular Biology Bioinformatics Data Analysis Creative Problem Solving Artificial Chromosome Transcription Fellowship Acquisition Grant Writing DNA electrophoresis RNA-Seq Bioinformatics GitHub Ubuntu Scientific Publishing Chromatin TT-Seq Strain Engineering Molecular Cloning Scientific Communications MNase-Seq Genome Assembly Professional Development Programs Python (Programming Language) DNA Extraction Scientific Presentation Epigenetics Data Science Data Modeling Molecular & Cellular Biology 5'-Seq 3'READS Biotechnology Biochemical and Molecular Biology Assays Scientific Writing Data Analysis Fluorescence Miscroscopy Genomics Lentivirus Data Synthesis and Bioinformatics RNA Biology Yeast Molecular Genetics Molecular Chaperones Heat shock proteins DNA/RNA/Protein High Throughput Studies NGS Protein Folding Transcription High Throughput Sequencing qRT-PCR rtPCR qPCR Anchor Away Recombinant Protein Purification Polymerase Chain Reaction PCR DNA electrophoresis RNA-Seq Bioinformatics Ubuntu Recombinant DNA Protein Assays DNaseI-Seq Mentoring Nucleosome Reconstitution Genetics Yeast two-hybrid Chromatin Column Chromatography Assay Development Transcription factor Digital genomic footprinting Protein Expression DNA Sequencing Strain Engineering Mammalian Cell Culture Immunofluorescence Molecular Cloning ChIP-Seq Scientific Communications Python (Programming Language) DNA Extraction Western Blotting Molecular Biology Scientific Presentation Epigenetics Proteomics qPCR Data Science Acetylation Assay Molecular & Cellular Biology Protein Purification E. coli In Vitro Transcription EMSA Fluorescence Anisotropy Biotechnology Biochemical and Molecular Biology Assays Digital Genomic Footprinting Scientific Writing Data Analysis Fluorescence Miscroscopy Genomics Data Synthesis and Bioinformatics RNA Biology Yeast Molecular Genetics Mass Spectrometry Polymerase Chain Reaction (PCR) Cancer Research DNA electrophoresis Activity Based Protein Profiling Protein Assays Column Chromatography Protein Expression Molecular Cloning Confocal Microscopy Microarray Analysis Western Blotting Molecular Biology Scientific Presentation Optogenetics Chemistry Bioorganic Chemistry Protein Purification E. coli Biotechnology Biochemical and Molecular Biology Assays Cellular Biophysics Scientific Writing Fluorescence Miscroscopy Microbiology Biotechnology Data Analysis Computational Chemistry Amber Molecular Dynamics Scientific Presentation Chemistry Scientific Writing Data Analysis Mass Spectrometry DART-MS Scientific Presentation TD-GS-MS Chemistry Scientific Writing Data Analysis Precision Medicine DNA Computers RNA synthetic biology genomics consulting biotechnology consulting genomics and biotechnology consulting genomics consulting services biotechnology consulting services genomic data analysis bioinformatics consulting drug discovery consulting genetic engineering consulting precision medicine consulting molecular biology consulting regulatory affairs consulting clinical trials consulting microbiome consulting synthetic biology consulting genomics consulting for pharmaceutical companies biotechnology consulting for startups genomic data analysis services bioinformatics support for research drug discovery consulting firm genetic engineering consulting for agriculture precision medicine consulting for patient care molecular biology consulting for academic institutions regulatory affairs consulting for medical devices microbiome consulting for gut health Investment opportunity venture capital private equity private equities collaboration scientist contract scientist biotechnology innovative research Investors Capital providers Equity investors Venture capitalists Angel investors early-stage startups Institutional investors startup consulting agency genomics consulting scientific help proofread science book publishing genome sequencing genome assembly variant analysis data mining data visualization bioinformatics pipeline development regulatory affairs consulting pharmaceutical companies biotechnology companies healthcare providers research institutions agricultural companies government agencies direct-to-consumer genomics companies
